Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 0 | 0 | 32 | 31 | 31 |
| Gross Profit | N/A | N/A | 32 | 31 | 31 |
| Operating Expenses | 9,579 | 9,633 | 8,134 | 8,912 | 8,784 |
| Operating Income | -9,579 | -9,633 | -8,102 | -8,881 | -8,753 |
| Interest Expense | 644 | 609 | 754 | 519 | 435 |
| Other Income | 609 | 1,447 | 3,773 | 712 | 5,039 |
| Pre-tax Income | -9,614 | -8,795 | -5,083 | -8,688 | -4,149 |
| Net Income Continuous | -9,614 | -8,795 | -5,083 | -8,688 | -4,149 |
| Net Income | $-9,614 | $-8,795 | $-5,083 | $-8,688 | $-4,149 |
| EPS Basic Total Ops | -0.33 | -0.30 | -0.18 | -0.30 | -0.14 |
| EPS Basic Continuous Ops | -0.33 | -0.30 | -0.18 | -0.30 | -0.14 |
| EPS Diluted Total Ops | -0.33 | -0.30 | -0.18 | -0.30 | -0.14 |
| EPS Diluted Continuous Ops | -0.33 | -0.30 | -0.18 | -0.30 | -0.14 |
| EBITDA(a) | $-9,343 | $-9,403 | $-7,881 | $-8,676 | $-8,566 |